Research by people – for people
World leader in peptide and peptidomimetic research
Ferring is a world leader in peptide andpeptidomimetic research and this forms an important part of the history of the company.
Ferring’s R&D activities are focused on the following key therapy areas: reproductive health, urology, gastroenterology and endocrinology.
In addition, in all therapy areas, Ferring pays particular attention to developing drug delivery systems that are effective and convenient for the patient.
We strive to maintain our leadership by:
- Focusing on novel peptide/hormone and protease genes;
- Further developing peptide and peptidomimetic science and technology;
- Adapting existing peptide based medications to meet specific medical needs;
- Developing effective and patient friendly drug delivery systems.
R&D Centres and Organisation
Select a centre
More than 100 Swedes cross the bridge between Denmark and Sweden each day to go to work at the International PharmaScience Center (IPC) in Copenhagen, where 24 nationalities work side by side in the 80m high building - one of the highest in Scandinavia.
http://www.ferring.dk
